.png)
glp 1 agonist in india GLP-1 Drugs India: 5× Market Growth by 2030 GLP‑1 Therapies: Transforming Obesity Treatment
Description
No adverse effects were documented
The analysis showed that metabolic surgery significantly reduced major adverse cardiovascular events over 3.9 years of follow-up, with a hazard ratio of 0.61
doi: 10.1016/j.cct.2024.107516 103 JastreboffAMAronneLJAhmadNNWhartonSConneryLAlvesBet al
Biologic therapies have transformed Crohn's disease management and include several FDA-approved options: TNF- inhibitors : Infliximab (Remicade), adalimumab (Humira), and certolizumab pegol (Cimzia) block tumor necrosis factor-alpha, a key pro-inflammatory cytokine
Learn more aboutGLP-1
